CC
PRCT icon

Centiva Capital’s Procept Biorobotics PRCT Stock Holding History

Centiva Capital’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$351K Buy
+15,562
New +$390K ﹤0.01% 1086
2025
Q4 		– Sell
-13,337
Closed -$476K – 1526
2025
Q3 		$476K Buy
+13,337
New +$609K ﹤0.01% 662
2025
Q2 		– Sell
-12,249
Closed -$714K – 1946
2025
Q1 		$714K Buy
+12,249
New +$836K 0.02% 642
2024
Q4 		– Sell
-7,550
Closed -$605K – 2257
2024
Q3 		$605K Buy
+7,550
New +$536K 0.01% 1117

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Centiva Capital's PRCT Position: Q2 2026 in Review

Centiva Capital opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 15,562 shares worth $351K. The stake represents ﹤0.01% of the portfolio and ranks #1086 among its holdings. This is a return to the name: Centiva Capital previously reported a position in PRCT as recently as Q3 2025.

Centiva Capital first reported a position in PRCT in Q3 2024 and has held it in 4 quarters since. The position peaked at $714K in Q1 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Centiva Capital held 15,562 shares of Procept Biorobotics worth $351K as of Q2 2026.
  • Procept Biorobotics was a new Centiva Capital position in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1086 holding.
  • Centiva Capital first reported a position in Procept Biorobotics in Q3 2024 and has held it in 4 quarters since.
  • Centiva Capital's Procept Biorobotics position peaked at $714K in Q1 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.